Time trends in cardiovascular and all-cause mortality in the 'old' and 'new' European Union countries

European Journal of Cardiovascular Prevention and Rehabilitation

Volumn 18, Issue 3, 2011, Pages 347-359

  Helis, Eftyhia ^a   Augustincic, Lana ^a   Steiner, Sabine ^a   Chen, Li ^a   Turton, Penelope ^a   Fodor, J George ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

All cause mortality; Cardiovascular disease mortality; European Union; Mortality comparison

Indexed keywords

ALL CAUSE MORTALITY; ARTICLE; AUSTRIA; BELGIUM; BULGARIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR DISEASE; CIRCULATORY SYSTEM DISEASE; CZECH REPUBLIC; DATA BASE; DENMARK; ESTONIA; EUROPEAN UNION; FINLAND; FRANCE; GERMANY; GREECE; HUMAN; HUNGARY; IRELAND; ISCHEMIC HEART DISEASE; ITALY; LATVIA; LITHUANIA; LUXEMBOURG; MORTALITY; NETHERLANDS; POLAND; PORTUGAL; PRIORITY JOURNAL; ROMANIA; SLOVAKIA; SLOVENIA; SPAIN; SWEDEN; TREND STUDY; UNITED KINGDOM; WORLD HEALTH ORGANIZATION;

CARDIOVASCULAR DISEASES; CAUSE OF DEATH; EUROPE; EUROPEAN UNION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TIME FACTORS;

EID: 79959256550     PISSN: 17418267     EISSN: 17418275     Source Type: Journal    
DOI: 10.1177/1741826710389361     Document Type: Article

References (47)

1. Kesteloot H, Sans S and Kromhout D. Dynamics of cardiovascular and all-cause mortality in Western and Eastern Europe between 1970 and 2000. Eur Heart J 2006; 27: 107-113.
2. Levi F, Chatenoud L, Bertuccion P, Lucchini F, Negri E and La Vecchia C. Mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world: an update. Eur J Cardiovasc Prev Rehabil 2009; 16: 333-350.
3. Müller-Nordhorn J, Binting S, Roll S and Willich SN. An update on regional variation in cardiovascular mortality within Europe. Eur Heart J 2008; 29: 1316-1326. (Pubitemid 351768126)
4. European Health for All Database (HFA-DB). WHO Regional Office for Europe, Copenhagen, Denmark http://www.euro.who.int/hfadb (accessed January 2009).
5. Levi F, Lucchini F, Negri E and La Vecchia C. Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world. Heart 2002; 88: 119-124. (Pubitemid 34787755)
6. Kim HJ, Fay MP, Feuer EJ and Mildtune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19: 335-351. (Pubitemid 30070608)
7. National Cancer Institute. Joinpoint Regression Program, version 3.4.2. http://srab.cancer.gov/joinpoint (October 2009).
8. Laatikainen T, Crtitchley J, Vartiainen E, Salomaa V, Ketonen M and Capewell S. Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am J Epidemiol 2005; 162: 764-773.
9. Björck L, Rosengren A, Bennett K, Lappas G and Capewell S. Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002. Eur Heart J 2009; 30: 1046-1056.
10. Kabir Z, Bennett K, Shelley E, Unal B, Critchley JA and Capewell S. Comparing primary prevention with secondary prevention to explaining decreasing coronary heart disease death rates in Ireland, 1985-2000. BMC Public Health 2007; 7: 117-123.
11. Unal B, Critchley JA and Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981-2000. Circulation 2004; 109: 1101-1107.
12. Ford ES, Ajani UA, Croft J, Critchley JA, Labarthe DR, Kottke TE, et al. Explaining the decrease in U.S. Deaths from coronary disease, 1980-2000. N Engl J Med 2007; 356: 2388-2398.
13. Zatonski WA, McMichael AJ and Powles JW. Ecological study of reasons for sharp decline in mortality from ischaemic heart disease in Poland since 1991. BMJ 1998; 316: 1047-1051.
14. Cifkova R, Skodova Z, Bruthans J, Adamkova V, Jozifova M, Galovcova M, et al. Longitudinal trends in major cardiovascular risk factors in the Czech population between 1985 and 2007/8. Czech MONICA and Czech post-MONICA. Atherosclerosis 2010; 211: 676-681.
15. Ulijaszek SJ and Koziel S. Nutrition transition and dietary energy availability in Eastern Europe after the collapse of communism. Econ Hum Biol 2007; 5: 359-369. (Pubitemid 350154515)
16. Studer M, Briel M, Leimenstoll B, Glass TR and Bucher HC. Effect of different antilipidemic agents and diets on mortality: a systemic review. Arch Intern Med 2005; 165: 725-730. (Pubitemid 40569423)
17. Howard BV, Van Horn L, Hsia J, Manson JE, Stefanick ML, Wassertheil-Smoller S, et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative randomized controlled dietary modification trial. JAMA 2006; 295: 655-666. (Pubitemid 43209067)
18. Knai C, Suhrcke M and Lobstein T. Obesity in Eastern Europe: an overview of its health and economic implications. Econ Hum Biol 2007; 5: 392-408. (Pubitemid 350176283)
19. Karmisholt K, Gyntelberg F and Gøtzche PC. Physical activity for primary prevention of disease. Systemic reviews of randomised clinical trails. Dan Med Bull 2005; 52: 86-89.
20. Eurobarometer 64.3 Health and Food. Fieldwork: November-December 2005. Brussels: European Commission, November 2006.
21. Ezzati M, Henley SJ, Thun MJ and Lopez AD. Role of smoking in global and regional cardiovascular mortality. Circulation 2005; 112: 489-497. (Pubitemid 41060788)
22. Strong K, Guthold R, Yang J, Lee D, Petit P and Fitzpatrick C. Tobacco use in the European region. Eur J Cancer Prev 2008; 17: 162-168. (Pubitemid 351301628)
23. The World Health Report 2002. Reducing Risks, Promoting Healthy Life. Geneva: World Health Organization, 2002.
24. Popova S, Rehm J, Patra J and Zatonski W. Comparing alcohol consumption in central and eastern Europe to other European countries. Alcohol 2007; 42: 465-473. (Pubitemid 47604053)
25. OECD Health Data 2008: statistics and indicators for 30 Countries. OECD Secretariat, Institut de Recherche et d'Etude en Economie de la Santé (IRDES), http://www. ecosante.org/oecd.htm (accessed December 2008).
26. Salmivaara AH, Lavikainen PT, Korhonen MJ, Halava H, Martikainen J, Saastamoinen LK, et al. Pattern of statin use among 10 cohorts of new users from 1995 to 2004: a register-based nationwide study. Am J Manag Care 2010; 16: 116-122.
27. Walley T, Folino-Gallo P, Schwabe U and Van Ganse E (on behalf of the EuroMedStat group). Variations and increase in use of statins across Europe: data from administrative databases. BMJ 2004; 328: 386-387.
28. Zdrojewski T, Wyrzykowski B, Szczech R, Wierucki Ł, Naruszewicz M, Narkiewicz K, et al. Steering Committees of Programmes NATPOL PLUS, SMS, Polish 400-CITIES Project. Epidemiology and prevention of arterial hypertension in Poland. Blood Press Suppl 2005; 2: 10-16.
29. Cífková R. Arterial hypertension as a public health issue in the Czech Republic. Blood Press Suppl 2005; 2: 25-28. (Pubitemid 43173242)
30. Dzerve V and Lejnieks A. Hypertension in Latvia - epidemiology and management. Blood Press Suppl 2005; 2: 29-32. (Pubitemid 43173243)
31. Redon J, Brunner HR, Ferri C, Hilgers KF, Kolloch R and van Montfrans G. Practical solutions to the challenges of uncontrolled hypertension: a white paper. J Hypertens Suppl 2008; 26: S1-S14.
32. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K and Keil U (EUROASPIRE Study Group). Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet 2009; 373: 929-940.
33. Allender S, Scarborough P, Peto V and Rayner M. European cardiovascular disease statistics 2008. Brussels: European Heart Network, 2008.
34. Müller-Nordhorn J, Rossnagel K, Mey W and Willich SN. Regional variation and time trends in mortality from ischaemic heart disease: East and West Germany 10 years after reunification. J Epidemiol Community Health 2004; 58: 481-485. (Pubitemid 38678535)
35. Brotman DJ, Golden SH and Wittstein IS. The cardiovascular toll of stress. Lancet 2007; 370: 1089-1100. (Pubitemid 47419001)
36. Rosengren A, Hawken S, Ounpuu S, Sliwa K, Zubaid M, Almahmeed WA, et al (INTERHEART investigators). Association of psychosocial risk factors with risk of acute myocardial infarction in 11,119 cases and 13,648 controls from 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 953-962A.
37. Ferrie JE, Martikainen P, Shipley MJ and Marmot MG. Self-reported economic difficulties and coronary events in men: evidence from the Whitehall II study. Int J Epidemiol 2005; 34: 640-648. (Pubitemid 40852581)
38. Stansfeld SA, Fuhrer R, Shipley MJ and Marmot MG. Psychological distress as a risk factor for coronary heart disease in the Whitehall II Study. Int J Epidemiol 2002; 31: 248-255. (Pubitemid 34284934)
39. Kristenson M, Kucinskienë Z, Bergdahl B, Calkauskas H, Urmonas V and Orth-Gomér K. Increased psychosocial strain in Lithuanian versus Swedish men: the LiVicordia study. Psychosom Med 1998; 60: 277-282. Erratum in: Psychosom Med 2003; 65: 346.
40. Kopp MS, Skrabski A and Szedmák S. Psychosocial risk factors, inequality and self-rated morbidity in a changing society. Soc Sci Med 2000; 51: 1351-1361. (Pubitemid 30412038)
41. O'Flaherty M, Bishop J, Redpath A, McLaughlin T, Murphy D, Chalmers J, et al. Coronary heart disease mortality among young adults in Scotland in relation to social inequalities: time trend study. BMJ 2009; 339: b2613.
42. Singh-Manoux A, Guéguen A, Martikainen P, Ferrie J, Marmot M and Shipley M. Self-rated health and mortality: short- and long-term associations in the Whitehall II study. Psychosom Med 2007; 69: 138-143. (Pubitemid 46667980)
43. Eurobarometer 66.3: European Social Reality. Fieldwork: November-December 2006. Brussels: European Commission, February 2007.
44. The World in 2005: The Economist Intelligence Unit's quality-of-life index. http://www.economist.com/media/ pdf/QUALITY-OF-LIFE.pdf. (accessed June 2009).
45. Law MR, Morris JK and Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomized trials in the context of expectations from prospective epidemiological studies. BMJ 2009; 338: b1665.
46. McManus RJ and Mant J. Management of blood pressure in primary care. BMJ 2009; 338: b940.
47. Fourth joint task force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur J Cardiovasc Prev Rehabil 2007; 14(Suppl 2): E1-E40.